Peptic ulcer epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
| Line 10: | Line 10: | ||
*The incidence of peptic ulcer disease is approximately 10-19 per 100,000 individuals worldwide.<ref name="pmid19220208">{{cite journal |vauthors=Sung JJ, Kuipers EJ, El-Serag HB |title=Systematic review: the global incidence and prevalence of peptic ulcer disease |journal=Aliment. Pharmacol. Ther. |volume=29 |issue=9 |pages=938–46 |year=2009 |pmid=19220208 |doi=10.1111/j.1365-2036.2009.03960.x |url=}}</ref> | *The incidence of peptic ulcer disease is approximately 10-19 per 100,000 individuals worldwide.<ref name="pmid19220208">{{cite journal |vauthors=Sung JJ, Kuipers EJ, El-Serag HB |title=Systematic review: the global incidence and prevalence of peptic ulcer disease |journal=Aliment. Pharmacol. Ther. |volume=29 |issue=9 |pages=938–46 |year=2009 |pmid=19220208 |doi=10.1111/j.1365-2036.2009.03960.x |url=}}</ref> | ||
*In 2011, the incidence rate of peptic ulcer disease was estimated to be one case per 1000 individuals and peptic ulcer complications is 0.7 per 1000 individuals.<ref name="pmid21626606">{{cite journal |vauthors=Lin KJ, García Rodríguez LA, Hernández-Díaz S |title=Systematic review of peptic ulcer disease incidence rates: do studies without validation provide reliable estimates? |journal=Pharmacoepidemiol Drug Saf |volume=20 |issue=7 |pages=718–28 |year=2011 |pmid=21626606 |doi=10.1002/pds.2153 |url=}}</ref> | *In 2011, the incidence rate of peptic ulcer disease was estimated to be one case per 1000 individuals and peptic ulcer complications is 0.7 per 1000 individuals.<ref name="pmid21626606">{{cite journal |vauthors=Lin KJ, García Rodríguez LA, Hernández-Díaz S |title=Systematic review of peptic ulcer disease incidence rates: do studies without validation provide reliable estimates? |journal=Pharmacoepidemiol Drug Saf |volume=20 |issue=7 |pages=718–28 |year=2011 |pmid=21626606 |doi=10.1002/pds.2153 |url=}}</ref> | ||
*The incidence and prevalence of H. pylori infection are generally higher among people born outside North America | *The incidence and prevalence of H. pylori infection are generally higher among people born outside North America. Within North America, the prevalence of the infection is higher in certain racial and ethnic groups, and people who have immigrated to North America | ||
===Prevalence=== | ===Prevalence=== | ||
Revision as of 15:26, 16 November 2017
|
Peptic ulcer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Surgery |
|
Case Studies |
|
2017 ACG Guidelines for Peptic Ulcer Disease |
|
Guidelines for the Indications to Test for, and to Treat, H. pylori Infection |
|
Guidlines for factors that predict the successful eradication when treating H. pylori infection |
|
Guidelines to document H. pylori antimicrobial resistance in the North America |
|
Guidelines for evaluation and testing of H. pylori antibiotic resistance |
|
Guidelines for when to test for treatment success after H. pylori eradication therapy |
|
Guidelines for penicillin allergy in patients with H. pylori infection |
|
Peptic ulcer epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Peptic ulcer epidemiology and demographics |
|
Risk calculators and risk factors for Peptic ulcer epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ;Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2]
Overview
Epidemiology and Demographics
A minority of cases of Helicobacter infection will eventually lead to an ulcer and a larger proportion of people will get non-specific discomfort, abdominal pain or gastritis. The prevalence of infection is greater in developing countries and is influenced by socioeconomic conditions, ethnic background and age.
Incidence
- The incidence of peptic ulcer disease is approximately 10-19 per 100,000 individuals worldwide.[1]
- In 2011, the incidence rate of peptic ulcer disease was estimated to be one case per 1000 individuals and peptic ulcer complications is 0.7 per 1000 individuals.[2]
- The incidence and prevalence of H. pylori infection are generally higher among people born outside North America. Within North America, the prevalence of the infection is higher in certain racial and ethnic groups, and people who have immigrated to North America
Prevalence
- The prevalence of peptic ulcer disease is approximately 23.1 per 100,000 individuals but higher in men 29.4 per 100,000 than women 14.9 per 100,000[3][1]
- The prevalence of peptic ulcer disease is estimated to be 4.5 million cases annually.[4][5]
- Lifetime prevalence is 11-14% in men and 8-11% in women
Case-fatality rate/Mortality rate
- In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
- The case-fatality rate/mortality rate of [disease name] is approximately [number range].
Age
- Peptic ulcer disease is acquired during childhood.
- The incidence of Peptic ulcer disease increases with age; the median age at diagnosis is years.
- Peptic ulcer disease commonly affects individuals older women than younger men.
- [Chronic disease name] is usually first diagnosed among [age group].
- [Acute disease name] commonly affects [age group].
Race
- Peptic ulcer disease usually affects individuals of the African Americans with a higher proportion of African ancestry race and Mexican Americans[6][7].Non-Hispanic whites individuals are less likely to develop the peptic ulcer disease.
Gender
- Peptic ulcer disease rates for male and female children are similar[8].
- Men are more commonly affected by peptic ulcer disease than women in adulhood[3].
The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
Region
East Asia
- The majority of peptic ulcer disease cases are reported in immigrants from East Asia[9][10].
- [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
Developed Countries
References
- ↑ 1.0 1.1 Sung JJ, Kuipers EJ, El-Serag HB (2009). "Systematic review: the global incidence and prevalence of peptic ulcer disease". Aliment. Pharmacol. Ther. 29 (9): 938–46. doi:10.1111/j.1365-2036.2009.03960.x. PMID 19220208.
- ↑ Lin KJ, García Rodríguez LA, Hernández-Díaz S (2011). "Systematic review of peptic ulcer disease incidence rates: do studies without validation provide reliable estimates?". Pharmacoepidemiol Drug Saf. 20 (7): 718–28. doi:10.1002/pds.2153. PMID 21626606.
- ↑ 3.0 3.1 Naja F, Kreiger N, Sullivan T (2007). "Helicobacter pylori infection in Ontario: prevalence and risk factors". Can. J. Gastroenterol. 21 (8): 501–6. PMC 2657974. PMID 17703249.
- ↑ Kuipers EJ, Thijs JC, Festen HP (1995). "The prevalence of Helicobacter pylori in peptic ulcer disease". Aliment. Pharmacol. Ther. 9 Suppl 2: 59–69. PMID 8547530.
- ↑ Pounder RE, Ng D (1995). "The prevalence of Helicobacter pylori infection in different countries". Aliment. Pharmacol. Ther. 9 Suppl 2: 33–9. PMID 8547526.
- ↑ Nguyen T, Ramsey D, Graham D, Shaib Y, Shiota S, Velez M, Cole R, Anand B, Vela M, El-Serag HB (2015). "The Prevalence of Helicobacter pylori Remains High in African American and Hispanic Veterans". Helicobacter. 20 (4): 305–15. doi:10.1111/hel.12199. PMID 25689684.
- ↑ Everhart JE, Kruszon-Moran D, Perez-Perez GI, Tralka TS, McQuillan G (2000). "Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States". J. Infect. Dis. 181 (4): 1359–63. doi:10.1086/315384. PMID 10762567.
- ↑ de Martel C, Parsonnet J (2006). "Helicobacter pylori infection and gender: a meta-analysis of population-based prevalence surveys". Dig. Dis. Sci. 51 (12): 2292–301. doi:10.1007/s10620-006-9210-5. PMID 17089189.
- ↑ Siao D, Somsouk M (2014). "Helicobacter pylori: evidence-based review with a focus on immigrant populations". J Gen Intern Med. 29 (3): 520–8. doi:10.1007/s11606-013-2630-y. PMC 3930769. PMID 24065381.
- ↑ Perez-Perez GI, Olivares AZ, Foo FY, Foo S, Neusy AJ, Ng C, Holzman RS, Marmor M, Blaser MJ (2005). "Seroprevalence of Helicobacter pylori in New York City populations originating in East Asia". J Urban Health. 82 (3): 510–6. doi:10.1093/jurban/jti093. PMC 3456059. PMID 16033932.